ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2011-11-22
    Description: Acetyl coenzyme A (AcCoA) is the central biosynthetic precursor for fatty-acid synthesis and protein acetylation. In the conventional view of mammalian cell metabolism, AcCoA is primarily generated from glucose-derived pyruvate through the citrate shuttle and ATP citrate lyase in the cytosol. However, proliferating cells that exhibit aerobic glycolysis and those exposed to hypoxia convert glucose to lactate at near-stoichiometric levels, directing glucose carbon away from the tricarboxylic acid cycle and fatty-acid synthesis. Although glutamine is consumed at levels exceeding that required for nitrogen biosynthesis, the regulation and use of glutamine metabolism in hypoxic cells is not well understood. Here we show that human cells use reductive metabolism of alpha-ketoglutarate to synthesize AcCoA for lipid synthesis. This isocitrate dehydrogenase-1 (IDH1)-dependent pathway is active in most cell lines under normal culture conditions, but cells grown under hypoxia rely almost exclusively on the reductive carboxylation of glutamine-derived alpha-ketoglutarate for de novo lipogenesis. Furthermore, renal cell lines deficient in the von Hippel-Lindau tumour suppressor protein preferentially use reductive glutamine metabolism for lipid biosynthesis even at normal oxygen levels. These results identify a critical role for oxygen in regulating carbon use to produce AcCoA and support lipid synthesis in mammalian cells.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710581/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710581/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Metallo, Christian M -- Gameiro, Paulo A -- Bell, Eric L -- Mattaini, Katherine R -- Yang, Juanjuan -- Hiller, Karsten -- Jewell, Christopher M -- Johnson, Zachary R -- Irvine, Darrell J -- Guarente, Leonard -- Kelleher, Joanne K -- Vander Heiden, Matthew G -- Iliopoulos, Othon -- Stephanopoulos, Gregory -- P30 CA014051/CA/NCI NIH HHS/ -- R01 CA122591/CA/NCI NIH HHS/ -- R01 DK075850-01/DK/NIDDK NIH HHS/ -- Howard Hughes Medical Institute/ -- England -- Nature. 2011 Nov 20;481(7381):380-4. doi: 10.1038/nature10602.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/22101433" target="_blank"〉PubMed〈/a〉
    Keywords: Acetyl Coenzyme A/biosynthesis/metabolism ; Aryl Hydrocarbon Receptor Nuclear Translocator/metabolism ; Basic Helix-Loop-Helix Transcription Factors/genetics/metabolism ; CD8-Positive T-Lymphocytes/cytology ; Carbon/metabolism ; Carcinoma, Renal Cell/metabolism/pathology ; *Cell Hypoxia ; Cell Line, Tumor ; Cells, Cultured ; Citric Acid Cycle ; Glutamine/*metabolism ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Isocitrate Dehydrogenase/deficiency/genetics/*metabolism ; Ketoglutaric Acids/metabolism ; Kidney Neoplasms/metabolism/pathology ; *Lipogenesis ; Oxidation-Reduction ; Oxygen/metabolism ; Palmitic Acid/metabolism ; Von Hippel-Lindau Tumor Suppressor Protein/genetics/metabolism
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2010-10-12
    Description: Taxol (paclitaxel) is a potent anticancer drug first isolated from the Taxus brevifolia Pacific yew tree. Currently, cost-efficient production of Taxol and its analogs remains limited. Here, we report a multivariate-modular approach to metabolic-pathway engineering that succeeded in increasing titers of taxadiene--the first committed Taxol intermediate--approximately 1 gram per liter (~15,000-fold) in an engineered Escherichia coli strain. Our approach partitioned the taxadiene metabolic pathway into two modules: a native upstream methylerythritol-phosphate (MEP) pathway forming isopentenyl pyrophosphate and a heterologous downstream terpenoid-forming pathway. Systematic multivariate search identified conditions that optimally balance the two pathway modules so as to maximize the taxadiene production with minimal accumulation of indole, which is an inhibitory compound found here. We also engineered the next step in Taxol biosynthesis, a P450-mediated 5alpha-oxidation of taxadiene to taxadien-5alpha-ol. More broadly, the modular pathway engineering approach helped to unlock the potential of the MEP pathway for the engineered production of terpenoid natural products.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034138/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034138/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Ajikumar, Parayil Kumaran -- Xiao, Wen-Hai -- Tyo, Keith E J -- Wang, Yong -- Simeon, Fritz -- Leonard, Effendi -- Mucha, Oliver -- Phon, Too Heng -- Pfeifer, Blaine -- Stephanopoulos, Gregory -- 1-R01-GM085323-01A1/GM/NIGMS NIH HHS/ -- R01 GM085323/GM/NIGMS NIH HHS/ -- R01 GM085323-02/GM/NIGMS NIH HHS/ -- New York, N.Y. -- Science. 2010 Oct 1;330(6000):70-4. doi: 10.1126/science.1191652.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Chemical Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/20929806" target="_blank"〉PubMed〈/a〉
    Keywords: Alkenes/*metabolism ; Bioreactors ; Cytochrome P-450 Enzyme System/genetics/metabolism ; Diterpenes/*metabolism ; Erythritol/analogs & derivatives/metabolism ; Escherichia coli K12/enzymology/genetics/*metabolism ; Farnesyltranstransferase/genetics/metabolism ; Fermentation ; *Genetic Engineering ; Hemiterpenes/metabolism ; Indoles/metabolism ; Isomerases/genetics/metabolism ; Metabolic Networks and Pathways/genetics ; Metabolomics ; NADPH-Ferrihemoprotein Reductase/genetics/metabolism ; Organophosphorus Compounds/metabolism ; Oxidation-Reduction ; Paclitaxel/*biosynthesis ; Recombinant Fusion Proteins/metabolism ; Sugar Phosphates/metabolism ; Taxoids/metabolism ; Taxus/enzymology ; Terpenes/metabolism
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...